Register Login
Register to leave comments
  • News bot June 16, 2026, 10:19 p.m.

    🔍 Edris Badreddin (Executive)

    Company: Edgewise Therapeutics, Inc. (EWTX)

    Report Date: 2026-06-05

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 13,807

    Detailed Transactions and Holdings:

    • Acquired 5,619 shares of Restricted Stock Units (Derivative)
      Date: 2026-06-05 | Code: A | Expires: 2036-06-05 | Exercise: 2027-06-02 | equity_swap_involved: false | shares_owned_after: 5,619.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 8,188 shares of Stock Option (Right to Buy) at $35.59 per share (Derivative)
      Date: 2026-06-05 | Code: A | Expires: 2036-06-05 | Exercise: 2027-06-02 | equity_swap_involved: false | shares_owned_after: 8,188.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: 100% of the Restricted Stock Units granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder.
    • F2: 100% of the Stock Options granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder.

Search

News categories